· and received fda pregnancy risk category d or x medicines during pregnancy than the unexposed...

7

Upload: others

Post on 29-Jul-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 2:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 3:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 4:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 5:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 6:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant
Page 7:  · and received FDA pregnancy risk category D or X medicines during pregnancy than the unexposed women (P = .005 and < .001, respectively). Orofacial Cleft We found no significant